OTCMKTS:CNXR

(CNXR) (CNXR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.35
$0.35
50-Day Range
N/A
52-Week Range
$0.35
$0.35
Volume
400 shs
Average Volume
78,068 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CNXR stock logo

About (CNXR) Stock (OTCMKTS:CNXR)

Connecture, Inc. provides a Web-based consumer shopping, enrollment and retention platform for health insurance distribution. The Company caters its services to health insurance marketplace operators, such as health plans, brokers and exchange operators. It operates through four segments: Enterprise/Commercial, Enterprise/State, Medicare and Private Exchange. The Enterprise/Commercial segment offers insurance distribution solutions to health plans. The Enterprise/State segment offers the sales automation solutions to state Governments, which allow its customers to offer customized individual and small group exchanges. The Medicare segment offers Web-based Medicare plan comparison, prescription drug comparison and enrollment tools for health plans, pharmacy benefit managers, pharmacies, field marketing organizations and call centers. The Private Exchange segment offers defined-contribution benefit exchange solutions to benefit consultants, brokers, exchange operators and aggregators.

CNXR Stock News Headlines

The Gold Grab of the Century
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
The Gold Grab of the Century
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
FLCB Enters Oversold Territory
See More Headlines
Receive CNXR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (CNXR) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/08/2016
Today
4/27/2024

Industry, Sector and Symbol

Industry
Prepackaged Software
Sub-Industry
N/A
Current Symbol
OTCMKTS:CNXR
Previous Symbol
NASDAQ:CNXR
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • David A. Jones Jr. (Age 67)
    Independent Chairman of the Board
  • Jeffery Surges (Age 49)
    President, Chief Executive Officer, Director
  • Brian Lindstrom (Age 46)
    Chief Financial Officer, Corporate Secretary
  • Vincent E. Estrada (Age 52)
    Executive Vice President - Corporate Development
  • David A. Sockel (Age 53)
    Executive Vice President - Strategy and Corporate Development
  • Lea DeVillers (Age 48)
    General Counsel
  • Mark E. Granville (Age 61)
    Chief Delivery Officer
  • Kraig McEwen
    Director
  • Ezra Perlman (Age 45)
    Director
  • A. John Ansay (Age 60)
    Independent Director

CNXR Stock Analysis - Frequently Asked Questions

How were (CNXR)'s earnings last quarter?

(CNXR) (OTCMKTS:CNXR) issued its earnings results on Monday, August, 8th. The technology company reported ($0.47) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.22) by $0.25. The technology company earned $18.70 million during the quarter, compared to the consensus estimate of $18.21 million. The firm's revenue for the quarter was down 19.9% on a year-over-year basis.

What other stocks do shareholders of (CNXR) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (CNXR) investors own include Biocept (BIOC), Novavax (NVAX), Rite Aid (RAD), Athersys (ATHX), Palatin Technologies (PTN), Acer Therapeutics (ACER), Alimera Sciences (ALIM), Allena Pharmaceuticals (ALNA) and

This page (OTCMKTS:CNXR) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners